Andrew Ip
Doctor Andrew Ip is a specialist in hematology/oncology at the John Theurer Cancer Center at Hackensack University Medical Center, USA. He has been involved in research on tocilizumab use in COVID-19 patients.-
Tocilizumab : a treatment alternative in COVID-19 pneumonia
Patients with severe COVID-19 pneumonia often need to be mechanically intubated and have an increased mortality risk. Tocilizumab, a drug used against the cytokine storm underlying this clinical condition, has shown positive effects in clinical trials.
-
A scientist’s opinion : Interview with Dr Andrew Ip about covid-19 treatment
Interview with Dr Andrew Ip, a specialist in hematology/oncology at the John Theurer Cancer Center at Hackensack University Medical Center, USA, who has been involved in research on tocilizumab use in COVID-19 patients. Why did you choose tocilizumab to treat patients with COVID-19 pneumonia? Andrew...